Dossier assessment

Ticagrelor - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

Status
Status: Commission completed
Project no.
A11-02
Last updated

Report documents

  1. Executive summary of dossier assessment

    Ticagrelor - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF document, 46 kB, EN, not accessible
  2. Dossier assessment

    Ticagrelor - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF document, 748 kB, DE, not accessible

Press releases

Ticagrelor: Considerable added benefit for specific patients

Fewer deaths and myocardial infarctions in unstable angina pectoris and NSTEMI / AMNOG procedure has passed the first practical test

Additional information

Federal Joint Committee (G-BA)

2011-12-15 A G-BA decision was published.

G-BA documents on this decision (German only)

Project details

Project no.
A11-02
Commission
Commission awarded on 24.01.2011 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Heart and circulation
Note

The patient representative involved belatedly corrected erroneous information on his potential conflicts of interest. IQWiG's letter to the Federal Joint Committee (German version)

Connected Projects

  1. Dossier assessment

    Ticagrelor (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A16-15
    Last updated

    Status: Commission completed

  2. Dossier assessment

    Ticagrelor - Consultation on content and completeness of the dossier

    Project no.
    A11-01
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form